surgery. Cases involving total synthetic corporal reconstruction were excluded.
surgery. Cases involving total synthetic corporal reconstruction were excluded.
RESULTS: 246 cases meeting inclusion criteria were identified. Mean patient age was 64.5 years, and mean follow-up was 28 months. Distribution involved 205 (83%) for primary placement, 37 (15%) for removal/replacement, and 4 (2%) in setting of prior device removal. Diabetes was noted in 29% of men. Trainee involvement was noted in 100% of cases. Rates of involvement by postgraduate year (PGY) were 81 (PGY2 or lower), 23 (PGY3), 12 (PGY4), 113 (PGY5), 112 (PGY6). Two operations were performed for suspected infection, one based on pain and one based on fever of unknown origin. Both were without intraoperative evidence of infection and all operative cultures were negative. One received simple removal/replacement and the other received removal with subsequent finding of pulmonary source for fever. Thus, the postoperative infection rate in this series was 0%.
CONCLUSIONS: In this contemporary series from an academic training center, infection following IPP surgery is uncommon, even with 100% involvement of surgeons-in-training. This data should be used to better inform PCPs and members of the general public potentially interested in restoration of sexual function. Fear of involving residents in IPP surgery appears to be unwarranted.
Source of Funding: None

PD25-04 MOLECULAR ANALYSIS USING PCR TO AMPLIFY EXTRACTED 16S RIBOSOMAL DNA APPEARS TO IDENTIFY BIOFILM AND ANTIMICROBIAL SENSITIVITIES/ RESISTANCES ON PENILE PROSTHESES IN-VIVO
Gary Tan*, Lauren Dawn, Christopher Smith, Gerard Henry, Shreveport, LA INTRODUCTION AND OBJECTIVES: Previous studies have used traditional culture methods to identify microbial biofilm composition present at removal and replacement of penile prostheses. Molecular analysis (PathoGenius Laboratories, Lubbock, TX) PCR amplifies extracted 16S ribosomal DNA, which is then sequenced and compared to known bacterial and fungal taxonomies to identify isolates and microbial susceptibilities. The purpose of this study was to identify biofilm compositions and antimicrobial sensitivities/resistances at penile prosthesis removal/replacement using 16S ribosomal DNA testing.
METHODS: Level 1 testing rapidly analyzed samples for most commonly found microbes in wound or ear, nose, and throat samples. Each sample composition was identified by quantitative PCR analysis with a specified panel of pathogens. Level 2 testing universally assessed for relative quantities of bacteria and fungi. DNA sequencing methods were used to identify the pathogens' genetic signatures and the estimated percentages of organisms present in each specimen. Biofilm pathogens were evaluated against 34 unique antimicrobial agents.
RESULTS: Intraoperative penile prosthesis capsule specimens were submitted for analysis at the time of revision surgery. Quantitative PCR analysis of common pathogens resulted in 14 specimens with low bacterial loads and 4 specimens with medium bacterial loads. 16S ribosomal DNA testing produced positive results in 5 of 18 specimens. One of these specimens had 2 separate fungi, while the other four positive specimens had 9, 13, 14, and 8 separate bacteria species respectively. Some of the bacteria identified during 16S ribosomal DNA testing were known prosthetic infectious pathogens. All isolates had sensitivities/resistances to 34 unique antimicrobial agents, enabling the physician to accurately tailor treatments for each patient.
CONCLUSIONS: 16S ribosomal DNA molecular testing has proven to be beneficial in its thorough analysis of biofilm composition and antimicrobial sensitivities/resistances on inflatable penile prostheses at the time of revision surgery. Future identification of biofilm and antimicrobial sensitivities/resistances may be improved with 16S ribosomal DNA molecular testing. 00 is a mesh that is used to approximate the medial aspects of the bilateral corporotomies at the time of IPP insertion. We hypothesize that, as the cylinders expand on inflation, this may help limit climacturia, as well as leakage in patients with minimal incontinence.
METHODS: We conducted a pilot multi-center study of patients with post-RP ED and climacturia and/or mild urinary incontinence (2pads/day) undergoing IPP insertion with concomitant placement of a 00 mini-jupette 00 graft. RESULTS: Seven patients underwent the 00 mini-jupette 00 procedure. The median age of the population was 61 years (53-70). Four patients had post-RP climacturia and 7 patients had post-RP incontinence (mean 1.9 pads/day [SD 0.4]). Four patients received a Coloplast Titan, 2 an AMS 700 LGX, and 1 an AMS 700 CX IPP. Mean corporotomy size was 3.2cm (1.3). Types of grafts used were Tutoplast pericardium in 4 patients, biomesh/polypropylene in 2, and Vypro-mesh in 1.Mean graft measurements were as follows: length 3.1cm (1.4), width 3.0cm (0.9), and surface area 9.6cm2 (7.6). No intra-operative or post-operative complications were reported at a mean follow-up of 2.7 months (1.5). Climacturia and incontinence were subjectively improved in 3 (75%) and 7 patients (100%), respectively. All patients were satisfied with the use of their IPP.
CONCLUSIONS: The 00 mini-jupette 00 procedure is an excellent, safe and easy technique that can be used for subsets of patients with post-RP climacturia and/or minimal incontinence. Longer follow-up and larger patient cohorts are needed to confirm the long term safety and benefits of this intervention.
Source of Funding: none
PD25-06 PRE-VAGINOPLASTY BILATERAL ORCHIECTOMY FOR TRANSGENDER WOMEN: AN EFFICIENT SURGICAL TECHNIQUE THAT PRESERVES COLLATERAL TISSUES AND SENSATION
Maurice Garcia*, San Francisco, CA INTRODUCTION AND OBJECTIVES: For M to F transgender women, bilateral orchiectomy provides significant medical benefit: if allows many patients to use a lower dose of estrogen (used for feminization). Estrogen at the high doses that transgender women require has significant cardiovascular risks. Bilateral orchiectomy also allows immediate and complete discontinuation of Spironolactone, a potent diuretic also commonly used for feminization. In general, patients not ready for vaginoplasty benefit from early bilateral orchiectomy. A technique specific for transgender patients which anticipates future vaginoplasty surgery by preserving collateral tissues to be used later with vaginoplasty, and which can be done via a minimally invasive approach, has not been described.
METHODS: We describe a trans-scrotal technique for bilateral orchiectomy via a single midline scrotal incision that excises the cord at the level of the external inguinal ring. In our experience, is fast/efficient, and is associated with very low post-operative pain and morbidity. Furthermore, this technique spares a little described adipose tissue pedicle that is superficial to the spermatic cord, and which we use to Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e503
